Galapagos Diversifies into Antibodies
By Sally Mardikian PhD
Pharma Deals Review: Vol 2008 Issue 102 (Table of Contents)
Published: 26 Nov-2008
DOI: 10.3833/pdr.v2008.i102.104 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Galapagos has entered into an agreement with MorphoSys to develop therapeutic antibodies from discovery through to Phase IIa clinical trials within the bone and joint disease area...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
Last Issue PDF
RSS